The question of why the so-called „Epstein list“ has not been fully released as of February 25, 2025, is a complex one, steeped in legal, political, and social considerations. While hundreds of pages of court documents related to Jeffrey Epstein have already been unsealed over the past year, including names of associates, victims, and others tangentially connected to his case, the anticipation of a definitive „client list“ or further explosive revelations persists. Recent statements from U.S. Attorney General Pam Bondi, who hinted at reviewing a substantial stack of Epstein-related documents as recently as February 20, 2025, have fueled speculation. Yet, the release has not materialized. Below is an analysis of possible reasons for this delay, grounded in available context and reasonable inference. One potential reason is legal and procedural hurdles. The Epstein case involves a sprawling web of civil lawsuits,… 

A novel tool for rapidly identifying the genetic „fingerprints“ of cancer cells may enable future surgeons to more accurately remove brain tumors while a patient is in the operating room, new research reveals. Many cancer types can be identified by certain mutations, changes in the instructions encoded in the DNA of the abnormal cells. Led by a research team from NYU Langone Health, the new study describes the development of Ultra-Rapid droplet digital PCR, or UR-ddPCR, which the team found can measure the level of tumor cells in a tissue sample in only 15 minutes while also being able to detect small numbers of cancer cells (as few as five cells per square millimeter). The researchers say their tool is fast and accurate enough, at least in initial tests on brain tissue samples, to become the first practical tool of… 

The global organoid services market share is projected to grow from US$3.03 billion in 2023 to US$15.01 billion by 2031, driven by the increasing demand for personalized medicine and innovative drug screening services. According to a comprehensive report from The Insight Partners, „Organoids Services Market Size and Forecast 2023 – 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report“ The global organoid services market is observing significant growth owing to the surging popularity of personalized drugs and increasing demand for innovative drug screening services. The report carries out an in-depth analysis of market trends, key players, and future opportunities. The organoid services market scope entails an array of services that are expected to determine the market performance in the coming years.